Review of Research on Xiao Chengqitang
10.13422/j.cnki.syfjx.20191648
- VernacularTitle:小承气汤的研究概况
- Author:
Wu-yi LI
1
;
Yan MENG
1
;
Huan CHEN
1
;
Hai-fang CHEN
1
;
Xiao-ying HUANG
1
;
Ming YANG
1
;
Wu-liang YANG
1
Author Information
1. Key Laboratory of Modern Preparation of Traditional Chinese Medicine (TCM), Ministry of Education, Jiangxi University of TCM, Nanchang 330004, China
- Publication Type:Research Article
- Keywords:
Xiao Chengqitang;
famous classical formulas;
dose conversation;
historical evolution;
origin of medicinal materials;
processing of decoction pieces;
clinical application
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2020;26(2):241-250
- CountryChina
- Language:Chinese
-
Abstract:
Xiao Chengqitang, derived from Treatise on Febrile Diseases, is composed of Rhei Radix et Rhizoma, Magnoliae Officinalis Cortex and Aurantii Fructus Immaturus. It is often used to treat Yangming Fushi light syndrome. This formula was included in the Catalogue of Ancient Classical Prescription (The First Batch), which has a high clinical application value. Current researches on the chemical composition, pharmacological effect and clinical application of Xiao Chengqitang have been carried out, but the history of Xiao Chengqitang is unclear and the dose conversation method is vague. It has great difficulties in clinical rational applications of Xiao Chengqitang and the research and development of its compound preparations. In this article, the literature reports on Xiao Chengqitang were summarized from the aspects of historical evolution, literature researching of Chinese herbs, dosage conversation method, modern research in case to clarify the historical context of Xiao Chengqitang and to provide basis for the clinical application and modern scientific research of this formula.
